Academic Activities

Education

Public Psychiatry Fellowship, Columbia University, NY
Visiting Research Fellowship, Department of Global Health and Social Medicine, Harvard Medical School, MA
Resident, Department of Psychiatry, Tufts University School of Medicine, MA (Now affiliated with University of Massachusetts Medical School, MA)
Dr. Mario Pagenel Fellowship in Global Mental Health Delivery, Department of Global Health and Social Medicine, Harvard Medical School, MA
Internship, Erasmus Hospital, Belgium
Doctor of Medicine, School of Medicine and Pharmacy, State University of Haiti.

Adjunct (Voluntary) Assistant Professor, Department of Psychiatry, University of Michigan Medical School, MI
Disclosure: The university does not support or endorse my private practice or any of its services.

PAST

Clinical Assistant Professor, Department of Psychiatry, University of Michigan Medical School, MI
Assistant Clerkship Director of Medical Student Education, Department of Psychiatry, University of Michigan Medical School, MI

Mentor and Supervisor of Psychiatric Nurse Practitioners and Social Workers as a Public Psychiatry Fellow at Columbia University, NY.
Chief Resident of Scholarly Activities, Department of Psychiatry, Baystate Medical Center, University of Massachusetts Medical School, MA

The Interventional Psychiatry Registry Pilot: Study tracking the long-term effectiveness and potential adverse effects of Ketamine, Transcranial Magnetic Stimulation (TMS), Electroconvulsive Therapy (ECT) services, and newly developed antidepressants.
The Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²): A longitudinal study focusing on understanding the heterogeneity, progression, and underlying biology of bipolar illness and accelerating translation of the findings into day-to-day practice.
Esketamine Nasal Spray: Understanding its efficacy without other medications for severe depression.

Improving Depression Via E-Health Access (IDEA) Study: Integrating self-help mental health apps and websites for depression into a primary care clinic.
Study to Promote Innovation in Rural Integrated Telepsychiatry (SPIRIT): A 5-year study conducted in primary care clinics in three states to promote access to care for severe and chronic mental illnesses.
The BIO-K Study: Developing biomarkers that could help predict response to intravenous ketamine for major depression and bipolar illnesses.

Click on these links to access the publications listed below:

Using IV ketamine for difficult-to-treat depression to identify biomarkers linked to remission of symptoms.
Assessing symptoms predicting engagement in psychotherapy and medication management for individuals in primary care clinics with complex mental illnesses in three states.
Looking at the acceptability and effectiveness of outpatient group psychiatric visits to increase access and reduce stigma for bipolar illnesses.
Looking at the consequences of recurring depression and the cautionary steps to stop antidepressants.
Evaluating the factors influencing decisions for video visits versus phone visits for psychiatric care during the COVID-19 Pandemic.